Children with Angelman syndrome respond to different types of rewards to promote learning, and the preferred type may vary based…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
In-person social engagement is more important for fostering imitative behaviors in children with Angelman syndrome than in typically-developing children, a…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
Neuren Pharmaceuticals has begun manufacturing of NNZ-2591, an investigational treatment for Angelman syndrome and other diseases, for use in…
Ovid Therapeutics‘ OV101 (gaboxadol) has been granted a rare…
Asklepios BioPharmaceutical (AskBio) and the University of North Carolina at Chapel Hill (UNC) have entered into an agreement…
A new rat model of Angelman syndrome (AS) involves complete deletion of the maternal UBE3A gene, which causes multiple behavioral…
A conceptual model describing how Angelman syndrome (AS) tends to manifest and affect a person with Angelman and those…
Nutrition is an important but under-discussed aspect of care in Angelman syndrome (AS), according to a case report that described…